LECIGON Trademark

Trademark Overview

On Thursday, February 15, 2018, a trademark application was filed for LECIGON with the United States Patent and Trademark Office. The USPTO has given the LECIGON trademark a serial number of 87798930. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 11, 2021. This trademark is owned by INTRANCE MEDICAL SYSTEMS INC.. The LECIGON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Parkinson's disease
lecigon

General Information

Serial Number87798930
Word MarkLECIGON
Filing DateThursday, February 15, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 10, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of Parkinson's disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 23, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameINTRANCE MEDICAL SYSTEMS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94104
Party NameINTRANCE MEDICAL SYSTEMS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94104

Trademark Events

Event DateEvent Description
Tuesday, October 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 11, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 11, 2020EXTENSION 5 GRANTED
Wednesday, December 9, 2020EXTENSION 5 FILED
Wednesday, December 9, 2020TEAS EXTENSION RECEIVED
Thursday, August 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 18, 2020EXTENSION 4 GRANTED
Tuesday, August 18, 2020EXTENSION 4 FILED
Tuesday, August 18, 2020TEAS EXTENSION RECEIVED
Friday, March 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 4, 2020EXTENSION 3 GRANTED
Wednesday, March 4, 2020EXTENSION 3 FILED
Wednesday, March 4, 2020TEAS EXTENSION RECEIVED
Thursday, June 20, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2019EXTENSION 2 GRANTED
Thursday, June 20, 2019EXTENSION 2 FILED
Thursday, June 20, 2019TEAS EXTENSION RECEIVED
Tuesday, March 5, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 4, 2019EXTENSION 1 GRANTED
Monday, March 4, 2019EXTENSION 1 FILED
Monday, March 4, 2019TEAS EXTENSION RECEIVED
Wednesday, February 13, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 13, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 11, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, September 4, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 10, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 20, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 1, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 31, 2018ASSIGNED TO EXAMINER
Friday, February 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 19, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

lecigon disease parkinson treatment preparations pharmaceutical